IDEXX Laboratories Inc (IDXX)
480.60
+4.78
(+1.00%)
USD |
NASDAQ |
May 03, 16:00
480.70
+0.10
(+0.02%)
After-Hours: 20:00
IDEXX Laboratories Accounts Receivable (Quarterly): 507.21M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 507.21M |
December 31, 2023 | 457.44M |
September 30, 2023 | 452.70M |
June 30, 2023 | 461.86M |
March 31, 2023 | 446.02M |
December 31, 2022 | 400.62M |
September 30, 2022 | 388.07M |
June 30, 2022 | 412.90M |
March 31, 2022 | 402.24M |
December 31, 2021 | 368.35M |
September 30, 2021 | 376.76M |
June 30, 2021 | 382.31M |
March 31, 2021 | 381.79M |
December 31, 2020 | 331.43M |
September 30, 2020 | 337.59M |
June 30, 2020 | 320.32M |
March 31, 2020 | 299.98M |
December 31, 2019 | 269.31M |
September 30, 2019 | 268.32M |
June 30, 2019 | 286.15M |
March 31, 2019 | 281.16M |
December 31, 2018 | 248.86M |
September 30, 2018 | 264.56M |
June 30, 2018 | 265.01M |
March 31, 2018 | 259.86M |
Date | Value |
---|---|
December 31, 2017 | 234.60M |
September 30, 2017 | 228.16M |
June 30, 2017 | 240.26M |
March 31, 2017 | 225.35M |
December 31, 2016 | 204.49M |
September 30, 2016 | 204.70M |
June 30, 2016 | 212.23M |
March 31, 2016 | 212.07M |
December 31, 2015 | 188.32M |
September 30, 2015 | 190.90M |
June 30, 2015 | 199.44M |
March 31, 2015 | 196.23M |
December 31, 2014 | 152.38M |
September 30, 2014 | 160.47M |
June 30, 2014 | 168.64M |
March 31, 2014 | 179.92M |
December 31, 2013 | 158.04M |
September 30, 2013 | 151.57M |
June 30, 2013 | 159.12M |
March 31, 2013 | 158.99M |
December 31, 2012 | 138.32M |
September 30, 2012 | 141.37M |
June 30, 2012 | 147.16M |
March 31, 2012 | 160.98M |
December 31, 2011 | 141.28M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
268.32M
Minimum
Sep 2019
507.21M
Maximum
Mar 2024
377.57M
Average
382.05M
Median
Accounts Receivable (Quarterly) Benchmarks
Stryker Corp | 3.473B |
Haemonetics Corp | 211.61M |
ResMed Inc | 779.26M |
Steris PLC | 964.02M |
Zoetis Inc | 1.293B |